JPS5455715A - Amino acid preparation - Google Patents

Amino acid preparation

Info

Publication number
JPS5455715A
JPS5455715A JP12132177A JP12132177A JPS5455715A JP S5455715 A JPS5455715 A JP S5455715A JP 12132177 A JP12132177 A JP 12132177A JP 12132177 A JP12132177 A JP 12132177A JP S5455715 A JPS5455715 A JP S5455715A
Authority
JP
Japan
Prior art keywords
amino acid
malate
acid preparation
free
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12132177A
Other languages
Japanese (ja)
Other versions
JPS6229415B2 (en
Inventor
Ichiro Senhata
Akihiko Washimi
Hiroshi Ito
Osamu Otsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP12132177A priority Critical patent/JPS5455715A/en
Publication of JPS5455715A publication Critical patent/JPS5455715A/en
Publication of JPS6229415B2 publication Critical patent/JPS6229415B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To provide an amino acid preparation for oral administration free from chlorine ion, and agreeably and safely administrable to patients of renal diseases without causing acidosis, wherein at least a part of the basic amino acids are converted to malic acid salt.
CONSTITUTION: An amino acid preparation containing lysine as a basic amino acid and free from chlorine ion, wherein the lysine is converted to lysince malate. The preparation may contain arginine (in the form of malate or free base), and histidine and/or ornithine (in the form of malate). The malate may be acidic or neutral salt. The malic acid is DL-or L-isomer, wherein L-isomer is preferable
COPYRIGHT: (C)1979,JPO&Japio
JP12132177A 1977-10-07 1977-10-07 Amino acid preparation Granted JPS5455715A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12132177A JPS5455715A (en) 1977-10-07 1977-10-07 Amino acid preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12132177A JPS5455715A (en) 1977-10-07 1977-10-07 Amino acid preparation

Publications (2)

Publication Number Publication Date
JPS5455715A true JPS5455715A (en) 1979-05-04
JPS6229415B2 JPS6229415B2 (en) 1987-06-25

Family

ID=14808345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12132177A Granted JPS5455715A (en) 1977-10-07 1977-10-07 Amino acid preparation

Country Status (1)

Country Link
JP (1) JPS5455715A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216118A (en) * 1982-06-11 1983-12-15 Morishita Seiyaku Kk Amino acid pharmaceutical preparation composition and its preparation
EP0758234A1 (en) * 1994-04-29 1997-02-19 Wake Forest University Method and composition for treating renal disease and failure

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROTE LISTE=1974 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216118A (en) * 1982-06-11 1983-12-15 Morishita Seiyaku Kk Amino acid pharmaceutical preparation composition and its preparation
JPH0322367B2 (en) * 1982-06-11 1991-03-26 Morishita Pharma
EP0758234A1 (en) * 1994-04-29 1997-02-19 Wake Forest University Method and composition for treating renal disease and failure
EP0758234A4 (en) * 1994-04-29 1997-06-25 Univ Wake Forest Method and composition for treating renal disease and failure

Also Published As

Publication number Publication date
JPS6229415B2 (en) 1987-06-25

Similar Documents

Publication Publication Date Title
MY110267A (en) Therapeutic agent.
SG114293G (en) Pharmaceutical compositions
JPS55153712A (en) Insulin pharmaceutical preparation and its production
IE791806L (en) Gastroprotective mollusc extract
JPS52139713A (en) Sustained release cefalexin preparations
JPS56140924A (en) Calcitonin pharmaceutical preparation
JPS5455715A (en) Amino acid preparation
JPS5350316A (en) Drug composition for oral administration
JPS5781409A (en) External plaster
DE2967551D1 (en) 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
ES8200363A1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them.
JPS57128635A (en) Pharmaceutical preparation of gamma-globulin for venoclysis
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
ES8401074A1 (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
JPS5391188A (en) Preparation of glycyl lysine
JPS5210207A (en) Process for preparation of high purity pulenol
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt
GB2060638B (en) Lysine and arginine 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid salts pharmaceutical compositions containing them and their use
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
JPS5543045A (en) Preparation of d-n-beta-oxalyl-alpha,beta-diaminopropionic acid, and hemostatic agent and blood platelet increasing agent containing said compound
JPS53113033A (en) Antihyperlipemics
JPS5287116A (en) Novel physiologically active peptide
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS643123A (en) Remedy for skin inflammation